You make an excellent point@2020Mustang. But to put it in perspective I first bought in on 6 Feb @ .043 - I think I've mentioned this many times, it was the day after the big increase after Nomgon 1. I read all day and night after that and thought this looked fantastic. In my personal holdings I ended up acquiring over 300,000 over the next few days. It went up and sideways for a couple of days and I considered myself pretty clever. I ended up down more than 60% through the Covid crash and things were looking ugly. It wasn't until 7 July - five months later - that the price got back to what I originally paid. Then things changed, and changed rapidly. I should say, so convinced was I of the potential of this great company that I significantly increased my holdings through my SMSF and Trust as well.
I'm not saying this to brag - Jesus Christ I've backed some duds over the years - but the fundamentals of this are fantastic and I'm looking forward to this being a 50 bagger for you from here. Although the price I originally purchased at seemed expensive for many months, now it looks incredibly cheap.
We always need to keep in mind this is a speculative stock. But it has amazing potential and is being run by people who have done it all before. We will be producing a product at a cheap price, proximate to our market, for which every credible analyst predicts exponentially increasing demand.
No one likes to lose, but the most you can lose is what you've invested - but the potential gains here could well be life changing. Hold firm (which you clearly are anyway).
Good luck and see you at the $1 party, or the $6 party!!!!
- Forums
- ASX - By Stock
- EXR
- Ann: Appendix 3Y
Ann: Appendix 3Y, page-26
-
- There are more pages in this discussion • 18 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add EXR (ASX) to my watchlist
|
|||||
Last
11.0¢ |
Change
-0.015(12.0%) |
Mkt cap ! $124.7M |
Open | High | Low | Value | Volume |
13.0¢ | 13.0¢ | 10.5¢ | $412.9K | 3.531M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
7 | 378431 | 11.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
11.5¢ | 210000 | 3 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
7 | 378431 | 0.110 |
5 | 448088 | 0.105 |
12 | 1034017 | 0.100 |
2 | 105550 | 0.099 |
2 | 125200 | 0.098 |
Price($) | Vol. | No. |
---|---|---|
0.115 | 210000 | 3 |
0.120 | 15000 | 1 |
0.130 | 39500 | 1 |
0.135 | 440000 | 7 |
0.140 | 174926 | 10 |
Last trade - 16.10pm 15/07/2024 (20 minute delay) ? |
Featured News
EXR (ASX) Chart |
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham / Dr Alan Dunton, MD & CEO / Non-Executive Director
James Graham / Dr Alan Dunton
MD & CEO / Non-Executive Director
SPONSORED BY The Market Online